Absci

Absci Days Payable Outstanding

The Days Payable Outstanding (DPO) of Absci (ABSI) as of Oct 18, 2026 is 85.67. In the previous year, Days Payable Outstanding (DPO) was 20.62 — a change of 315.41% (higher).

Days Payable Outstanding

85.67

YoY

315.41%

Last updated:

Days Payable Outstanding (DPO) of Absci is 2025 85.67 . Days Payable Outstanding (DPO) of Absci was 2024 20.62 . It decreases by 315.41% higher compared to the previous year.

The Absci Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2019
22.69 USD
Jan 1, 2020
67.47 USD
Jan 1, 2021
68.64 USD
Jan 1, 2022
14.94 USD
Jan 1, 2023
11.53 USD
Jan 1, 2024
20.62 USD
Jan 1, 2025
85.67 USD
The Absci Days Payable Outstanding history
YEARDays Payable OutstandingYoY
85.67+315.41%
20.62+78.81%
11.53-22.83%
14.94-78.23%
68.64+1.75%
67.47+197.32%
22.69—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Absci Stock analysis

What does Absci do? Absci Corp, trading under the ticker ABSI with ISIN US00091E1091, is a biotechnology company headquartered in Vancouver, Washington, operating within the Health Care sector. The company went public via an IPO on July 22, 2021. Absci employs 140 people. It leverages artificial intelligence and synthetic biology to explore and expand the therapeutic potential of proteins. The company utilizes a platform combining AI with scalable wet lab technologies to develop biologics for patients. Absci's approach involves identifying novel drug targets, discovering biotherapeutic candidates, and generating cell lines for manufacturing within a single integrated process. The firm applies generative AI to design drug candidates optimized for target affinity, safety, manufacturability, and other characteristics. Absci's technology includes SoluPro, a multiplex synthetic biology method that addresses limitations of high-throughput automation labs. The company supports its AI-driven designs with high-throughput functional validation capabilities in its wet lab. Absci's website is www.absci.com, providing information about its services and technology. The company focuses on creating biologic drug candidates for partners, using data generated from its processes to refine and improve its platform. Absci is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Absci stock

Days Payable Outstanding (DPO) of Absci is 85.67 in 2025.

Days Payable Outstanding (DPO) of Absci changed from 20.62 to 85.67, representing a 315.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Absci since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Absci with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Absci

All Key Metrics — Absci